Female

AI, Inclusion, and Sustainability: Must-Haves for Business School Aspirants

Retrieved on: 
Tuesday, March 26, 2024
Sanitation, Growth, Hunger, Education, School, GMAC, Research, Female, Rest, Student, Woman, Curriculum, Innovation system, Nursing

What’s also driving the interest in advanced business education of would-be students is the transformative technology of generative artificial intelligence (AI).

Key Points: 
  • What’s also driving the interest in advanced business education of would-be students is the transformative technology of generative artificial intelligence (AI).
  • Candidate demand for it grew 38 percent year-over-year, with two-fifths now saying it is essential to their curricula.
  • Interest was the highest among those from the Middle East and Latin America as well as among millennials and men.
  • Global interest in STEM-certified business programs also grew 38 percent in five years—and to new heights in Asia, driven by demand in India and Greater China.

Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2

Retrieved on: 
Tuesday, March 26, 2024
Conference, Immunoglobulin A, Female, Aes, FIH, SARS-CoV-2, Volunteering, Trial of the century, Male, OMV, Vaccination, Safety, Vaccine, Immunoglobulin G, Administration

The phase I clinical trial, which was conducted in Australia, assessed the tolerability, safety and immunogenicity of the Avacc 10® vaccine.

Key Points: 
  • The phase I clinical trial, which was conducted in Australia, assessed the tolerability, safety and immunogenicity of the Avacc 10® vaccine.
  • In a randomized, double-blinded, placebo and OMV controlled study, 36 healthy 18-55 year-old, male and female volunteers, received two intranasal doses, 3 weeks apart.
  • Dr. Dinja Oosterhoff, Intravacc’s VP of Research & Development, stated:
    “This FIH intranasal vaccine study marks a significant milestone for Intravacc’s flagship OMV based vaccine platform.
  • Now Intravacc is also developing an intranasal vaccine for Gonorrhea targeting the FIH in Q4 2025.

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

Retrieved on: 
Monday, March 25, 2024
ODD, Research, Food and Drug Administration, U.S. FDA, Drug discovery, AML, International, Patient, Committee, SBIR, Female, Acute myeloid leukemia, Sale, INN, Marker, EMA, OTS, NIH, IND, Myelodysplastic syndrome, European Medicines Agency, Counsel, Therapy, MRD, Bone marrow, USAN, MDS, APOLLO, FDA, DLBCL, Press release, CD19, Pharmaceutical industry

Marker also executed a comprehensive non-dilutive agreement with Cell Ready which included a sale of select cell manufacturing assets from Marker for approximately $19 million in cash.

Key Points: 
  • Marker also executed a comprehensive non-dilutive agreement with Cell Ready which included a sale of select cell manufacturing assets from Marker for approximately $19 million in cash.
  • Granted ODD from the Committee for Orphan Medicinal Products of the EMA for the treatment of patients with AML in 2023.
  • On June 26, 2023, Marker completed a non-dilutive transaction with Cell Ready, under which Cell Ready purchased certain cell manufacturing assets from Marker for approximately $19 million in cash.
  • Cash Position and Guidance: At December 31, 2023, Marker had cash and cash equivalents of $15.1 million.

Nurse.com’s 2024 Nurse Salary and Work-Life Report Reveals Workplace Violence and Mental Health Concerns

Retrieved on: 
Tuesday, April 9, 2024
Managed Care, General Health, Training, Technology, Other Education, Continuing, Hospitals, Education, Nursing, Practice Management, Other Technology, Health, Community, RN, Certification, Culture, Grief, Psychological trauma, Risk, Patient, Violence, Mental health, APRN, RNS, Female, Fear, Death, Male, BSN, Verbal abuse, Safety, Assault, Workplace violence

For the first time in this biennial survey, nurses were asked about their experiences with workplace violence and how their job affected their mental health and wellness.

Key Points: 
  • For the first time in this biennial survey, nurses were asked about their experiences with workplace violence and how their job affected their mental health and wellness.
  • Many nurses also expressed a need for greater emphasis on physical and mental health.
  • “Workplace violence in any healthcare setting impacts both staff well-being and patient care quality.
  • Participation in this study increased significantly from the 2022 Nurse Salary Research Report , with 3,662 nurses surveyed this year.

Effective Management, AI Upskilling Key to Retaining and Advancing Women in Tech, Reveals Skillsoft Report

Retrieved on: 
Tuesday, April 9, 2024
Technology, Mobile, Wireless, Training, Continuing, Artificial Intelligence, Other Technology, Telecommunications, Software, Education, Networks, Internet, Data Management, Security, Satellite, Qualtrics, Organization, Learning, Mentorship, Woman, Trust, Risk, Lead, Scrum, Female, Emotional intelligence, SKIL, Empowerment, Managed services, Nursing

Skillsoft (NYSE: SKIL), a leading platform for transformative learning experiences, today released its annual Women in Tech Report examining the current realities, needs, and opportunities for women in the technology industry.

Key Points: 
  • Skillsoft (NYSE: SKIL), a leading platform for transformative learning experiences, today released its annual Women in Tech Report examining the current realities, needs, and opportunities for women in the technology industry.
  • When asked which tech-related topic they are most interested in learning about, the greatest portion of respondents said AI (41%).
  • The top pieces of advice for women pursuing tech-related careers include investing in education, finding mentors, and building power skills.
  • Only 27% of women in tech report being extremely satisfied with their jobs, and 37% are considering switching roles in the next year.

Robins Kaplan LLP Files Complaint Against Social Media Giants Meta, Snap, TikTok on Behalf of Spirit Lake Nation, Menominee Indian Tribe of Wisconsin

Retrieved on: 
Tuesday, April 9, 2024
Mental Health, Legal, Class Action Lawsuit, Native American, Communications, Professional Services, Social Media, Consumer, Health, Other Professional Services, Snap Inc., Public health, Tribe, Robins Kaplan LLP, Spirit Lake Tribe, Defendant, Meta Platforms, Social media, Behavior informatics, CNN, Female, LLP, Alphabet Inc., Adolescence, Complaint, CDC, ByteDance, Policy, Youth

Today, Robins Kaplan LLP filed a first-of-its-kind lawsuit on behalf of the Spirit Lake Tribe in North Dakota and the Menominee Indian Tribe of Wisconsin against entities that include Facebook and Instagram parent company Meta Platforms, Inc., Snap Inc., TikTok parent company ByteDance, and Alphabet Inc., which owns YouTube and Google.

Key Points: 
  • Today, Robins Kaplan LLP filed a first-of-its-kind lawsuit on behalf of the Spirit Lake Tribe in North Dakota and the Menominee Indian Tribe of Wisconsin against entities that include Facebook and Instagram parent company Meta Platforms, Inc., Snap Inc., TikTok parent company ByteDance, and Alphabet Inc., which owns YouTube and Google.
  • The complaint alleges that rampant social media addiction for Native American teenagers is contributing to suicide rates that are staggeringly higher than their adolescent counterparts.
  • The Center for Native American Youth notes that Tribal teen suicide rates are roughly 3.5 times higher than the national average in the United States.
  • We are demanding these social media corporations take responsibility for intentionally creating dangerous features that ramp up the compulsive use of social media by the youth on our Reservation.”
    The complaint details how U.S.

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

Retrieved on: 
Monday, April 8, 2024
Professional Services, Natural Resources, Cannabis, DEI (Diversity, Equity and Inclusion), Woman, Business, Female, TSX, Parity, Workforce, OGI, Management

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender diversity.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender diversity.
  • Fifty percent of the Company’s executive leadership team, including its CEO, are women.
  • The Women Lead Here benchmark was established in 2020 and applies a proprietary research methodology to provide an overview of the largest Canadian corporations with the highest degree of gender diversity among executive ranks.
  • “We are thrilled to be recognized yet again by the Globe & Mail for the gender diversity within our leadership team.

LIB Therapeutics Announces Positive Results from LIBerate-HR Study: A 52-Week, Placebo-Controlled Registration-Enabling Trial of Lerodalcibep at Late-Breaking Session at American College of Cardiology 2024

Retrieved on: 
Monday, April 8, 2024
Science, Cardiology, Biotechnology, Research, Pharmaceutical, Health, Clinical Trials, Other Health, Week, Temperature, Cardiovascular disease, PCSK9, CVD, ADAS, FH, Patient, Travel, Female, Refrigeration, OLE, MBBS, Marketing, European Medicines Agency, American College, Therapy, Liberation, ITT, Safety, Food, ACC, Apolipoprotein B, Apolipoprotein, Pharmaceutical industry

Patients were randomized 2:1 to a single 300 mg (1.2 mL subcutaneous) once-monthly dose of Lerodalcibep or placebo for 52 weeks.

Key Points: 
  • Patients were randomized 2:1 to a single 300 mg (1.2 mL subcutaneous) once-monthly dose of Lerodalcibep or placebo for 52 weeks.
  • Of 478 participants in the base LIBerate-HeFH trial, 421 (88%) continued into the OLE trial: 281 patients on Lerodalcibep and 140 on placebo.
  • All participants received open-label Lerodalcibep 300 mg in a subcutaneous 1.2 mL once-monthly dose starting immediately upon completion of the base trial.
  • After 48 weeks of OLE treatment, mean % LDL-C reductions with Lerodalcibep from baseline in the base trial was 48.5% (ITT population).

US Cyber Games® Recruiting New Women's Team to Compete Globally

Retrieved on: 
Tuesday, April 9, 2024
Conference, Communication, Woman, Female, Athlete, Commerce, Exhibition, Workforce, Kunoichi

ASHBURN, Va., April 9, 2024 /PRNewswire/ -- The US Cyber Games ® program, led by Katzcy ®, proudly announces the commissioning of the new US Women's Cyber Team .

Key Points: 
  • ASHBURN, Va., April 9, 2024 /PRNewswire/ -- The US Cyber Games ® program, led by Katzcy ®, proudly announces the commissioning of the new US Women's Cyber Team .
  • The US Women's Cyber Team will participate in global cyber competitions, focusing on attack and defense formats that align with in-demand cybersecurity careers.
  • Jessica Gulick, US Cyber Team Commissioner, emphasizes, "The creation of the US Women's Cyber Team is a step forward in addressing gender disparity within the cybersecurity industry.
  • The US Women's Cyber Team will proudly represent the USA at the Kunoichi Cyber Games.

Michelle Penczak Makes Inc.'s 2024 Female Founders List

Retrieved on: 
Tuesday, April 9, 2024
Employment, Organization, Female, Unemployment, Rihanna, Empathy, Food, Shoe, Woman, Empowerment, Spouse, Cryptocurrency

WILMINGTON, N.C., April 9, 2024 /PRNewswire-PRWeb/ -- Inc. today announced its seventh annual Female Founders list, honoring a bold group of 250 women whose innovations and ideas are shaping the world into a better place.

Key Points: 
  • Female Founder validates everything I have done in my professional career," said Michelle Penczak, CEO and Co-Founder of Squared Away .
  • The female founders on this year's list are a testament to what triumph over adversity looks like.
  • To see the complete list, go to: https://www.inc.com/female-founders
    After launching in 2018, the Female Founders list is one of Inc.'s most esteemed franchises.
  • Inc. magazine's Female Founders issue (April 2024) will be available online on April 9 at https://www.inc.com/magazine and on newsstands on April 16.